Gastroenterology Archives

Gastroenterology

Study: Health care organizations reduce SSIs by nearly half with Joint Commission project

A 2.5-year project under the direction of the Joint Commission Center for Transforming Healthcare in collaboration with the American College of Surgeons reduced surgical…

FDA approves new drug for irritable bowel syndrome and constipation

On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome…

JAMA: Use of anesthesia services for GI endoscopies increased substantially

A study in JAMA found that use of anesthesia services for gastrointestinal endoscopies and colonoscopies “increased substantially” between 2003 and 2009. Anesthesia use was…

Polypectomy lowers colorectal cancer mortality

A study in the New England Journal of Medicine reports that mortality from colorectal cancer was about 50% lower among patients who had adenomatous…

Unraveling the enigma of irritable bowel syndrome

Common, complex, and chronic, IBS can markedly decrease the quality of life and work productivity. But by using an integrated approach, you can help…

Study finds radiofrequency ablation effective for Barrett’s esophagus

Radiofrequency ablation for Barrett’s esophagus with dysplasia has an acceptable safety profile and is associated with a low rate of disease progression, for up…

Women have better outcomes than men after major GI surgery

Women who undergo major gastrointestinal (GI) surgery are less likely to die in the hospital than men according to a retrospective analysis of 307,124…

Managing dysphagia in elderly patients

The risk of developing dysphagia (difficulty swallowing) increases with age and exposure to aging-related diseases and conditions. Roughly 7% to 10% of adults older…

NEJM: Perspective on foodborne diseases

The Feb. 23 issue of The New England Journal of Medicine (NEJM) includes a perspective on foodborne disease. Read it at http://www.nejm.org/doi/full/10.1056/NEJMp1010907.

Fidaxomicin reduces C. diff recurrence

Compared to vancomycin, patients treated with fidaxomicin for Clostridium difficile infection were significantly less likely to have a recurrence. Read more here.

Evidence-based interventions for constipation in patients with cancer

Editor’s note: One of a series of articles on managing cancer-related symptoms from the Oncology Nursing Society. Constipation is a common but often unrecognized…

The genetics of colorectal cancer

A 52-year-old patient arrives at the busy family practice office where you work for his follow-up visit. He had not undergone colon cancer screening,…

Study: Health care organizations reduce SSIs by nearly half with Joint Commission project

A 2.5-year project under the direction of the Joint Commission Center for Transforming Healthcare in collaboration with the American College of Surgeons…

FDA approves new drug for irritable bowel syndrome and constipation

On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable…

JAMA: Use of anesthesia services for GI endoscopies increased substantially

A study in JAMA found that use of anesthesia services for gastrointestinal endoscopies and colonoscopies “increased substantially” between 2003 and 2009. Anesthesia…

Polypectomy lowers colorectal cancer mortality

A study in the New England Journal of Medicine reports that mortality from colorectal cancer was about 50% lower among patients who…

Unraveling the enigma of irritable bowel syndrome

Common, complex, and chronic, IBS can markedly decrease the quality of life and work productivity. But by using an integrated approach, you…